Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort
Jeffrey C. Kwong(University Health Network), Jonathan B. Gubbay(Great Ormond Street Hospital), Susan E. Richardson(University of Toronto), Michael A. Campitelli(Mount Sinai Hospital), Laura C. Rosella(University of Toronto), George Zahariadis(Western University), James Dayre McNally(Children's Hospital of Eastern Ontario), Andrew E. Simor(Sunnybrook Health Science Centre), Natasha S. Crowcroft(University of Toronto), Aaron Campigotto(University of Toronto), Michael L. Jackson(Kaiser Permanente Washington Health Research Institute), Hannah Chung, Sarah A. Buchan(University of Toronto), David Richardson(William Osler Health System), Kevin Katz, Marek Smieja(Hamilton Regional Laboratory Medicine Program), Kevin L. Schwartz(St. Michael's Hospital), Timothy Karnauchow(University of Ottawa), Allison McGeer(Sinai Hospital)
Cited by 41
Related Papers
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
|New England Journal of Medicine|2018|1.2k
Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study
|The Lancet|2021|300
Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons
|JAMA Network Open|2018|236
A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season
|Clinical Infectious Diseases|2016|232
Obesity and Respiratory Hospitalizations During Influenza Seasons in Ontario, Canada: A Cohort Study
|Clinical Infectious Diseases|2011|199